FeesSafety
Pluang+

PetMed Express reports Q2 sales down 19%, narrows net loss to $6.4M as it focuses on cost cuts and growth.

Company Fundamentals
10 Nov 2026, 23:05 WIB
GlobeNewsWire
View Source
Bearish
PetMed Express reports Q2 sales down 19%, narrows net loss to $6.4M as it focuses on cost cuts and growth.

PetMed Express announced its Q2 2026 financial results with net sales falling 19.4% to $35.8 million, mainly due to lower prescription medication sales and increased promotions. Despite a net loss of $6.4 million, the company improved from last year's $8.5 million loss by cutting administrative and advertising expenses. CEO Jeff Willard highlighted efforts to transform the business by reducing customer acquisition costs and enhancing the brand and website to drive profitability and future growth. The company remains focused on stabilizing operations and returning to growth.

PetMed Express's Q2 2026 financial results provide context for health-sector market activity. For readers following the health sector, here is Pluang's market snapshot as of Nov 11, 2026 04:02 WIB: out of 150 priced US health stocks, 52 rose and 97 fell. Notable movers include IONS at USD 28.10 with a 1-day change of -9.35%, CRSP at USD 45.67 down 8.73%, and TNGX at USD 24.60 up 8.18%.

More News

Cannabis Strategic Ventures completes control change with Scopien Technologies, rebrands and plans SEC listing.

Cannabis Strategic Ventures completes control change with Scopien Technologies, rebrands and plans SEC listing.

Cannabis Strategic Ventures has finalized its change of control with Scopien Technologies, an AI platform company, which now holds voting control through preferred stock. The company has appointed new leadership, including CEO Zameer Mulla, and plans...

Company Fundamentals
Bullish
3 hours ago
Star Bulk releases 2025 ESG report highlighting sustainability progress and future goals

Star Bulk releases 2025 ESG report highlighting sustainability progress and future goals

Star Bulk Carriers Corp. has published its 2025 Environmental, Social and Governance (ESG) Report, its eighth annual report detailing the company's sustainability strategy, performance, and future objectives. The report, guided by the ESG Committee, ...

Others
Bullish
3 hours ago
TELA Bio cuts operating loss 21% in Q3 2026, boosts international sales and extends cash runway to 2028

TELA Bio cuts operating loss 21% in Q3 2026, boosts international sales and extends cash runway to 2028

TELA Bio reported $19 million revenue in Q3 2026, down 8% year-over-year but with an 18% increase in international sales. The company reduced its operating loss by 21% sequentially and improved adjusted EBITDA loss by 55%, driven by a strategic cost ...

Company Fundamentals
Bullish
3 hours ago
Auburn National Bancorporation declares $0.27 quarterly dividend payable December 28, 2026.

Auburn National Bancorporation declares $0.27 quarterly dividend payable December 28, 2026.

Auburn National Bancorporation, Inc. announced a quarterly cash dividend of $0.27 per share, payable on December 28, 2026, to shareholders recorded by December 10, 2026. The company is the parent of AuburnBank, an Alabama state-chartered bank with ab...

Company Fundamentals
Neutral
5 hours ago
Québécois plan to dine out more in 2027, seeking value and local favorites, says OpenTable report.

Québécois plan to dine out more in 2027, seeking value and local favorites, says OpenTable report.

OpenTable's 2027 Quebec dining trends report shows a 9% increase in restaurant bookings, with 65% of Quebecers planning to dine out as much or more in 2027. Consumers prioritize value, local favorites, and meaningful experiences, often celebrating sm...

Market News
Bullish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App